Literature DB >> 5052728

Adverse reactions during rifampicin treatment.

N Riska, K Mattson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5052728

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


× No keyword cloud information.
  6 in total

Review 1.  Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.

Authors:  Thomas C Havey; Christine Cserti-Gazdewich; Michelle Sholzberg; Jay S Keystone; Wayne L Gold
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors:  Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

Review 3.  New trends in the chemotherapy of tuberculosis--current aspects.

Authors:  M Zierski
Journal:  Pneumonologie       Date:  1974-06-14

4.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  [Hepatic damage in patients treated with rifampicin (author's transl)].

Authors:  A Entz; D Kozma; E Vincze; M Balázs; K Vámos
Journal:  Pneumonologie       Date:  1974-09

Review 6.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.